文献速递炎症性肠病

MFSD2A促进内皮细胞生成炎症消退脂质介质并减轻小鼠结肠炎

MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice.
PubMed 文献 · Gastroenterology · 2017-08-04

研究探讨MFSD2A如何调节肠道内皮细胞脂质代谢以促进肠道炎症消退。活动期溃疡性结肠炎患者结肠活检中DHA来源的促炎症消退环氧代谢物水平低于健康对照和炎症消退组织,HIMECs生成这些代谢物依赖MFSD2A;过表达MFSD2A的内皮祖细胞移植可减轻小鼠结肠炎。

要点

  • 活动期UC患者结肠组织中DHA来源的促炎症消退环氧代谢物水平低于健康结肠组织和炎症消退组织。
  • HIMECs生成这些代谢物需要MFSD2A,MFSD2A是肠道血管中DHA滞留和代谢所必需的。
  • 过表达MFSD2A的内皮祖细胞移植可定位于炎症黏膜并恢复内皮消退肠道炎症的能力,减轻小鼠结肠炎。

核心结论

  • UC患者结肠组织中DHA来源的环氧化物水平低于健康黏膜和炎症消退黏膜。
  • 肠道内皮生成这些代谢物需要MFSD2A;过表达MFSD2A的内皮祖细胞可减轻小鼠结肠炎。
  • 该通路或可被诱导以消退结肠炎患者的肠道炎症。

研究设计与样本

  • 对活动期UC、炎症消退UC患者及无UC健康对照的手术标本黏膜活检和原代人肠道微血管内皮细胞(HIMECs)进行脂质组学和功能分析。
  • 用短发夹RNA敲低或慢病毒载体过表达HIMECs中的MFSD2A。
  • 将过表达MFSD2A的人循环内皮祖细胞转移至葡聚糖硫酸钠诱导结肠炎的CD1裸鼠,联合或不联合口服DHA。

主要发现

  • 活动期UC患者结肠活检中DHA来源的促炎症消退环氧代谢物水平低于健康结肠组织和炎症消退组织。
  • HIMECs生成这些代谢物需要MFSD2A,MFSD2A是肠道血管中DHA滞留和代谢所必需的。
  • 过表达MFSD2A的内皮祖细胞移植定位于炎症黏膜并恢复内皮消退肠道炎症的能力,与未接受过表达MFSD2A内皮祖细胞的结肠炎小鼠相比可减轻结肠炎。

临床怎么用

  • 原文结论提出该通路或可被诱导以消退结肠炎患者的肠道炎症。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Alterations in signaling pathways that regulate resolution of inflammation (resolving pathways) contribute to pathogenesis of ulcerative colitis (UC). The resolution process is regulated by lipid mediators, such as those derived from the ω-3 docosahexaenoic acid (DHA), whose esterified form is transported by the major facilitator superfamily domain containing 2A (MFSD2A) through the endothelium of brain, retina, and placenta. We investigated if and how MFSD2A regulates lipid metabolism of gut endothelial cells to promote resolution of intestinal inflammation. METHODS: We performed lipidomic and functional analyses of MFSD2A in mucosal biopsies and primary human intestinal microvascular endothelial cells (HIMECs) isolated from surgical specimens from patients with active, resolving UC and healthy individuals without UC (controls). MFSD2A was knocked down in HIMECs with small hairpin RNAs or overexpressed from a lentiviral vector. Human circulating endothelial progenitor cells that overexpress MFSD2A were transferred to CD1 nude mice with dextran sodium sulfate-induced colitis, with or without oral administration of DHA. RESULTS: Colonic biopsies from patients with UC had reduced levels of inflammation-resolving DHA-derived epoxy metabolites compared to healthy colon tissues or tissues with resolution of inflammation. Production of these metabolites by HIMECs required MFSD2A, which is required for DHA retention and metabolism in the gut vasculature. In mice with colitis, transplanted endothelial progenitor cells that overexpressed MFSD2A not only localized to the inflamed mucosa but also restored the ability of the endothelium to resolve intestinal inflammation, compared with mice with colitis that did not receive MFSD2A-overexpressing endothelial progenitors. CONCLUSIONS: Levels of DHA-derived epoxides are lower in colon tissues from patients with UC than healthy and resolving mucosa. Production of these metabolites by gut endothelium requires MFSD2A; endothelial progenitor cells that overexpress MFSD2A reduce colitis in mice. This pathway might be induced to resolve intestinal inflammation in patients with colitis.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Ungaro F, Tacconi C, Massimino L, et al. MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice. Gastroenterology. 2017. PMID: 28827082. doi:10.1053/j.gastro.2017.07.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。